Physician
Aspen Medical Group LLC
Aspen Medical Group LLC was paid $6.40M by Medicaid between Jan 2018 and Dec 2024, across 34 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoASPEN MEDICAL GROUP LLC
SANTA FE, NM 87507
SANTA FE, NM 87507
33aNPI1740533967assigned 10/25/2012
33bProvider typeFamily Medicine Physician
28Total paid$6.40M
24GClaims97,805
24DCodes billed34
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in New Mexico
Rank by total paid#11 of 148
Median peer was paid$167K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,155 | $763K | |
| 2019 | 13,829 | $683K | |
| 2020 | 9,894 | $518K | |
| 2021 | 11,874 | $795K | |
| 2022 | 18,678 | $1.31M | |
| 2023 | 15,638 | $1.21M | |
| 2024incomplete | 11,737 | $1.13M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 30,504 | 29,675 | $2.11M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 19,274 | 18,534 | $1.85M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13% | 8,288 | 8,158 | $832K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6.1% | 4,161 | 4,102 | $389K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.1% | 2,290 | 2,238 | $326K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.8% | 6,434 | 6,363 | $310K |
| 99441 | 1.9% | 2,300 | 2,243 | $123K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.7% | 3,004 | 2,975 | $109K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 6,305 | 3,126 | $94K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 4,590 | 4,541 | $69K |
| 99051 | <1% | 1,240 | 1,226 | $42K | |
| 99408 | <1% | 1,851 | 1,833 | $29K |
22 more codes
| H0049 | Alcohol and/or drug screening | <1% | 1,051 | $26K |
| 87634 | <1% | 317 | $21K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 201 | $21K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,155 | $18K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 311 | $10K |
| 81002 | <1% | 3,361 | $8K | |
| 99442 | <1% | 30 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 269 | $3K |
| 0012A | <1% | 67 | $3K | |
| 81025 | <1% | 277 | $2K | |
| 0011A | <1% | 66 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 31 | $1K |
| 90674 | <1% | 40 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 52 | $1K |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | <1% | 16 | $814.83 |
| 90756 | <1% | 25 | $497.79 | |
| 87807 | <1% | 36 | $468.60 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 80 | $120.76 |
| 86580 | <1% | 12 | $90.42 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 12 | $52.88 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14 | $16.24 |
| 91301 | <1% | 141 | $1.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROPP, ANDREW (CEO)